As a global leader with over 35 years of experience in bioanalytical testing, we understand the uphill battle of navigating the intricate scientific hurdles, extensive timelines, and rigorous regulatory landscape of drug development. Moreover, we recognize that substantial investment costs compounded by high failure rates can feel insurmountable, which is why we have expanded our toolbox with state-of-the-art DiscoveryAI services and products.
Our dedicated team of top data scientists, medicinal chemists, and machine learning engineers worked together to harness the power of AI technology to develop a suite of predictive tools to expedite key stages of the drug discovery life cycle. The DiscoveryAI platform aims to simplify complexities, reduce timelines and slash up to 30% of investment costs through early identification of safety and efficacy liabilities.
These AI solutions redefine the landscape by enabling researchers to further navigate the vast chemical space containing billions of potential drug molecules. Our DiscoveryAI technology proves cost effective in combination with our end-to-end laboratory services to maximize your investment’s potential by accelerating processes without compromising quality.
The result is exceptional support in your work bringing life-changing medications to those in need, harnessing AI to bridge the gap between groundbreaking innovation and impactful patient outcomes.
Benefit of Choosing Eurofins DiscoveryAI:
- Decades of Experience: With over 35 years of foundational expertise, we merge seasoned knowledge and proprietary datasets such as BioPrint and BioMAP® with the prowess of artificial intelligence
- Customized Solutions: Our flexible engagement model offers customized computational approaches with off-the-shelf experimental assays as a full-service drug discovery partner
- AI-Powered Solutions: Our cutting-edge AI tools offer predictive analytics and data-driven insights, streamlining processes without sacrificing quality
- Accelerated Discoveries: Reduce costs by over 30% and fast-track your molecule’s journey to the clinic
- Exploration Without Barriers: Expand your reach across the vast chemical landscape
With Eurofins DiscoveryAI SAFIRE, Let’s Revolutionize Drug Discovery Together!
Are you ready to gain your competitive edge by utilizing DiscoveryAI products and services where we combine the newest technologies in AI and machine learning (ML) with powerful Eurofins Discovery proprietary resources such as BioPrint and BioMAP®? In the complex realm of drug discovery, let us stand as your beacon of innovation and efficiency. Partner with us to revolutionize your drug discovery journey, unlocking breakthroughs and reshaping the future of healthcare.
Click below to try our new DiscoveryAI SAFIRE tool for predicting ADMET properties for FREE!
